Smart trial asthma pdf

Ideally, asthma therapy should provide effective, longterm control using the least amount of medication in order to minimize the risk of side effects (3) . SCHLÜSSELWÖRTER: Asthma, Budesonid/Formoterol, Exazerbationen, Erhaltungs- und. Bedarfstherapie, prädiktive Faktoren, Symbicort SMART. ZUGEHÖRIGKEIT. SMART-Studie (Salmeterol Multicenter Asthma. Research Trial), 6/1996-1/2003. • SNS-Studie (Serevent Nationwide Surveillance. Study), publiziert 1993